Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Kidney: Papillary renal cell carcinoma

Identity

Other nameschromophilic renal cell carcinoma

Classification

Note renal cell carcinomas form a heterogeneous group of tumours which can be divided into several subgroups according to their cytology, architecture, and the part of the nephron from which tumour cells are derived: five basic cell types are recognized: clear-cell, chromophilic-cell (also called papillary renal cell carcinomas (PRCC), herein described), chromophobic-cell, oncocytic-cell, and collector duct cell types a certain correlation exists between cell type and architecture of the tumour: the clear-cell type tends to show compact growth, while the chromophilic-cell type is more readily associated with tubulo-papillary architecture

Clinics and Pathology

Etiology a hereditary form, called Hereditary papillary renal cell carcinoma, of autosomal dominant transmission, has been recently recognized; it predisposes to develop multiple, bilateral renal tumours
Epidemiology papillary renal cell carcinomas (PRCC) represent about 10% of all renal cell tumours; there is a clear excess of male patients (male to female ratio: 5 to 1)
Pathology
  • papillary renal tumours are composed of at least 50% of papillary structures, formed by connective tissue stalks covered by small or medium size cuboid cells with eosinophilic or basophilic granular cytoplasm
  • renal cortical adenomas are frequently associated with PRCC in the same kidney, suggesting the possibility of transformation from adenoma to carcinoma
  • Cytogenetics

    Note except a very rare subtype characterized by a translocation t(X;1)(p11;q21) or other abnormalities involving Xp11, PRCC do not show a recurrent structural chromosome rearrangement, but display non random numerical abnormalities; this contrasts with clear-cell renal cell carcinomas which are associated with various deletions of 3p PRCC are characterized by loss of Y chromosome in men, trisomy or tetrasomy 7 and 17, trisomies 16, 20, and 12, by order of frequency; these chromosome imbalances have been confirmed by genomic comparative hybridization multifocal PRCC show the same numerical anomalies, with trisomies sometimes in various combinations in tumours within the same kidney or in both kidneys the confrontation of karyotypic abnormalities with histopathological data suggest that specific chromosome imbalances may make it possible to distinguish benign papillary adenoma from malignant PRCC; the small papillary tumours without any morphological or clinical sign of malignancy are characterized by a combination of loss of Y, and excess of chromosomes 7 and 17, only, whereas tumours with aggressive growth and metastatic dissemination show more complex karyotypic changes, in addition to polysomy 7 and 17; it is suggested that tumours with tri- or tetrasomy 7 and 17 correspond to papillary adenomas, and that tumours with more complex karyotypic changes are papillary carcinomas, irrespective of their size

    Genes involved and Proteins

    Note in hereditary PRCC, linkages studies have shown that the gene of the disease could be located at 7q31.1-34, between markers D7S496 and D7S1837, an interval containing the MET proto-oncogene; missense mutations in the tyrosine kinase domain of the MET gene have been identified in the germline of affected members of PRCC families, and in a subset of sporadic PRCC

    Bibliography

    Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements, and their use for diagnosis.
    Thoenes W, StÒrkel S, Rumpelt HJ.
    Pathol Res Pract 1986; 181: 125-143.
    PMID 86286944
     
    Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.
    Kovacs G.
    Am J Pathol 1989; 134: 27-34
    PMID 89116344
     
    Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L, Duh FM, Chen F, et al.
    Nature Genetics 1997; 16: 68-73.
    PMID 97285124
     
    Cytogenetics of papillary renal cell tumors.
    Kovacs G, Fuzesi L, Emanuel A, Kung HF.
    Genes Chromosomes & Cancer 1991; 3: 249-255.
    PMID 92068913
     
    Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma.
    Dal Cin P, Stas M, Sciot R, De Wever I, Van Damme B, Van den Berghe H.
    Cancer Genet Cytogenet 1998; 101: 58-61.
    PMID 98121834
     
    Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
    Hughson MD, Johnson LD, Silva FG, Kovacs G.
    Modern Pathol 1993; 6: 449-456 ().
    PMID 94022240
     
    Molecular cytogenetics of renal cell tumors.
    Kovacz G.
    Adv Cancer Res 1993; 62: 89-124.
    PMID 94152364
     
    Chromosome imbalances in papillary renal cell carcinoma and first cytogenetical data of familial cases analysed by comparative genomic hybridization.
    Bentz M, Bergerheim USR, Li C., et al.
    Cytogenet. Cell Genet. 1996; 75: 17-21.
    PMID 97150945
     
    Cytogenetic investigation of synchronous bilateral renal tumors.
    Dal cin P, van Poppel H, van Damme B, Baert L, Van den Berghe H
    Cancer Genet Cytogenet 1996; 89: 57-60.
    PMID 96280759
     
    REVIEW articlesautomatic search in PubMed
    Last year publicationsautomatic search in PubMed

    Contributor(s)

    Written05-1998Jérome Couturier

    Citation

    This paper should be referenced as such :
    Couturier J . Kidney: Papillary renal cell carcinoma. Atlas Genet Cytogenet Oncol Haematol. May 1998 .
    URL : http://AtlasGeneticsOncology.org/Tumors/kidney5003.html

    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Thu Apr 17 14:14:57 2008


    Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    j.l.huret@chu-poitiers.fr.